lunes, 23 de febrero de 2026
Deepfakes raise profound ethical questions in science Ankit Singh | AZO Robotics | February 23, 2026
https://geneticliteracyproject.org/2026/02/23/deepfakes-raise-profound-ethical-questions-in-science/
Much of the public concern around deepfakes has focused on abuse, particularly non-consensual intimate imagery, political misinformation, and the erosion of trust in audio-visual evidence. These issues are real and can have serious implications.
Epidemiology and risk factors of malaria in Cabo Verde, 2015–2023, in the elimination era Graça Maria Carvalho Mendes Moniz* [1] , António Lima Moreira [2] , Adilson José DePina [3]
https://www.academia.edu/academia-global-and-public-health/1/1/10.20935/AcadPHealth8078
Introduction: Cabo Verde was certified as malaria-free by the World Health Organization (WHO) in January 2024, becoming the fourth African nation to achieve this status. This study examines the epidemiological characteristics and associated factors of malaria cases in Cabo Verde from 2015 to 2023 to inform sustainable prevention strategies. Materials and methods: A retrospective, cross-sectional analysis was conducted using national surveillance data from 706 confirmed cases of malaria. Descriptive statistics and binary logistic regression were employed to identify factors associated with autochthonous versus imported cases. Statistical analyses were performed using SPSS v29.0.1.0. Results: Most cases (74.5%) occurred in males, with the highest incidence among individuals aged 20–54 years. The municipality of Praia accounted for 98.5% of autochthonous cases and 55% of imported cases. Fever (52.7%), headache (36.4%), and myalgia (20.4%) were the most common symptoms. Plasmodium falciparum caused all autochthonous infections, while imported cases included P. vivax, P. ovale, P. malariae, and mixed infections. Logistic regression identified fever (OR = 2.90; 95% CI: 1.24–6.78) and treatment with artemisinin-based combination therapy (ACT) plus primaquine (OR = 7.72; 95% CI: 1.12–53.29) as significant predictors of autochthonous cases. Chills were associated with imported cases (OR = 0.15; 95% CI: 0.07–0.29). Conclusions: Despite achieving malaria-free status, Cabo Verde remains vulnerable to imported cases due to its connectivity with endemic regions and receptivity level. Enhanced fever surveillance, targeted screening of travelers, and sustained vector control are critical to preventing reintroduction.
https://www.academia.edu/journals/academia-global-and-public-health/articles?source=journal-top-nav
Morning Briefing: Today's News Summaries Monday, Feb 23 2026 UPDATED 9:11 AM +++ +++ +
Morning Briefing: Today's News Summaries
Monday, Feb 23 2026 UPDATED 9:11 AM
High Court's Tariff Ruling Likely Won't Affect Deals Struck With Drugmakers
The Trump administration may impose sector-specific tariffs if pharmaceutical companies stray from most-favored-nation pricing for prescriptions, Managed Healthcare Executive reported. The administration is also looking at other statutes that would allow the use of tariffs to further its policy priorities.
https://kffhealthnews.org/morning-breakout/high-courts-tariff-ruling-likely-wont-affect-deals-struck-with-drugmakers/
Trump's EPA Supports Biden Admin's 10-Year Deadline To Replace Lead Pipes
Meanwhile, President Donald Trump says he'll deploy a hospital ship to Greenland, but Greenlandic Prime Minister Jens-Frederik Nielsen says, “It’s a no thank you from here." Also in the news: Jay Bhattacharya, glyphosate, ICE, and more.
https://kffhealthnews.org/morning-breakout/trumps-epa-supports-biden-admins-10-year-deadline-to-replace-lead-pipes/
With Nearly 1,000 Infections, Measles Tally Is Outpacing 2025's Case Count
More than half of the states have confirmed measles cases, with South Carolina, Utah, and Arizona experiencing widespread outbreaks. Meanwhile, five more children have died from the flu, which is still circulating at high levels across much of the country.
https://kffhealthnews.org/morning-breakout/with-nearly-1000-infections-measles-tally-is-outpacing-2025s-case-count/
Ransomware Attack Forces Closure Of All University Of Mississippi Clinics
The extent of the attack is still being evaluated at one of the state’s largest health care providers. Roughly three dozen clinics around the state were forced to close, and elective procedures have been canceled. Officials are warning the shutdown could continue for days.
https://kffhealthnews.org/morning-breakout/ransomware-attack-forces-closure-of-all-university-of-mississippi-clinics/
New Mexico Will Investigate History Of Forced Sterilization Of Native Women
Last week, legislators in New Mexico approved a measure to investigate the history and impact of forced and coerced sterilization of women of color in the state. Also in the news: abortion in Wyoming, elderly health care in California, and more.
https://kffhealthnews.org/morning-breakout/new-mexico-will-investigate-history-of-forced-sterilization-of-native-women/
Study Sheds Light On Why Women Are More Prone To Chronic Pain Than Men
The study, published Friday in Science Immunology, suggests that men's immune systems have higher levels of cells with a mechanism that switches off pain signals to the brain. Plus: autism, heart disease in women, SUIDS in recalled sleepers, and more.
https://kffhealthnews.org/morning-breakout/study-sheds-light-on-why-women-are-more-prone-to-chronic-pain-than-men/
Viewpoints: Policies That Help Hospital Giants Need To Be Changed; Human Toll Of Trump’s Anti-Science Stance
https://kffhealthnews.org/morning-breakout/viewpoints-policies-that-help-hospital-giants-need-to-be-changed-human-toll-of-trumps-anti-science-stance/
No one in health care should be called a ‘provider’ It’s a matter of ethics and professionalism
https://www.statnews.com/2026/02/23/provider-ethical-objections-physician-acp/
By Lois Snyder SulmasyFeb. 23, 2026
Snyder Sulmasy is the director of the American College of Physicians Center for Ethics and Professionalism.
Novo Nordisk’s next-gen obesity drug stumbles in comparison study The results add to the challenges facing the one-time leader in the weight loss market
https://www.statnews.com/2026/02/23/novo-nordisk-cagrisema-fail-comparison-trial-zepbound-eli-lilly-obesity/
By Andrew JosephFeb. 23, 2026
Europe Correspondent
Health care reform might be a focus in midterms. For Congress, pursuing it will be an uphill climb Lowering costs would be politically popular, but Republicans would face a host of challenges
https://www.statnews.com/2026/02/23/health-care-reform-midterms-trump/
By John WilkersonFeb. 23, 2026
Washington Correspondent
A provocative proposal asks the FDA to let some AI devices on the market without review Petition would shift the burden of evidence to post-market monitoring for six product types
https://www.statnews.com/2026/02/23/harrisonai-fda-petition-exempt-ai-devices-premarket-review/
By Mario Aguilar and Katie PalmerFeb. 23, 2026
Gilead to buy Arcellx in nearly $8B deal The two companies were already partnered on a multiple myeloma CAR-T treatment
https://www.statnews.com/2026/02/23/gilead-arcellx-acquisition-car-t-multiple-myeloma/
By Adam FeuersteinFeb. 23, 2026
Adam Feuerstein, a senior writer and biotech columnist, is the author of Adam’s Biotech Scorecard, a subscriber-only newsletter about the crossroads of drug development, business, Wall Street, and biotechnology.
Pharma lobbyists focus on a surprising new target: the FDA The FDA has long been shielded from political influence, but that’s changing under Trump
https://www.statnews.com/2026/02/23/fda-lobbying-efforts-grow-under-trump-administration/
By Daniel Payne and Lizzy LawrenceFeb. 23, 2026
Daniel Payne and Lizzy Lawrence interviewed lobbyists and government officials and reviewed corporate disclosures for this story.
MORE ON THE TRUMP ADMINISTRATION +++ +++
MORE ON THE TRUMP ADMINISTRATION
AP: Trump Says He Will Send A Hospital Ship To Greenland But The Territory's Leader Says No Thanks
https://apnews.com/article/greenland-trump-denmark-us-b2624bb6ed7d66de874e333779c505fe?utm_campaign=KHN%3A%20First%20Edition&utm_medium=email&_hsenc=p2ANqtz-8ztMYqH4rDggma8lK2iK6QOY8ZntwD5Haq1874YZNglUTcjGA8iy422jN21O8guEDL8XCNi8KH84T-uOjnbqZlQZG6Ug&_hsmi=405016981&utm_content=405016981&utm_source=hs_email
U.S. President Donald Trump said he would deploy a hospital ship to Greenland, alleging that many people there are sick and not receiving care, even though both of the U.S. Navy’s hospital ships are currently docked at a shipyard in Alabama. Trump’s announcement prompted a defense on Sunday of Denmark and Greenland’s health care system from their leaders, and it was the latest point of friction with the American leader who has frequently talked about seizing the massive Arctic territory. “It’s a no thank you from here,” said Greenlandic Prime Minister Jens-Frederik Nielsen. (Keaten and Toropin, 2/22)
AP: Trump Administration Backs 10-Year Deadline To Replace Harmful Lead Pipes
https://apnews.com/article/trump-lead-pipes-drinking-water-contamination-epa-6e1c7c45f1ba41ae69dfb13fa9510ef8?utm_campaign=KHN%3A%20First%20Edition&utm_medium=email&_hsenc=p2ANqtz--RKn52SSQI0yiqhfi_NZ6BdrLEy-PvhGNucy5rplt-FsWvB8M_Z5Vf6DPso54opPkhGMzUTFBQla1rxriWyEGstPE-xw&_hsmi=405016981&utm_content=405016981&utm_source=hs_email
The Trump administration said Friday it backs a 10-year deadline for most cities and towns to replace their harmful lead pipes, giving notice that it will support a tough rule approved under the Biden administration to reduce lead in drinking water. The Environmental Protection Agency told a federal appeals court in Washington that it would defend the strongest overhaul of lead-in-water standards in three decades against a court challenge by a utility industry association. (Phillis, 2/21)
Stat: Petition Pushes FDA To Exempt AI Devices From Premarket Review
https://www.statnews.com/2026/02/23/harrisonai-fda-petition-exempt-ai-devices-premarket-review/?utm_campaign=KHN%3A%20First%20Edition&utm_medium=email&_hsenc=p2ANqtz-9GgB7kcohgZFRGaMFn2gGWHhWrYG0A9ieZjxAWejQxudBXql-KRKkhUpwF57W_KtjZjXb61Hi458l-eBpgG5yfP5m0uA&_hsmi=405016981&utm_content=405016981&utm_source=hs_email
The Trump administration has promised to reduce the barriers between health artificial intelligence developers and patients. With a provocative new proposal, an AI company has offered regulators a way to let a broad swath of potentially risky AI devices flood the market. (Aguilar and Palmer, 2/23)
Stat: Pharma Companies Turn To Trump-Connected Firms For FDA Lobbying
https://www.statnews.com/2026/02/23/fda-lobbying-trump-connected-firms-cash-in/?utm_campaign=KHN%3A%20First%20Edition&utm_medium=email&_hsenc=p2ANqtz-8BrpOT0EyAFOdppAyfMm83NuuJ4gzTuw8o5-BLoNmkeg4OlBybrD_L-PtSFQ30_cpFfv9VimXpMTvQf76kRdKfwTvJOA&_hsmi=405016981&utm_content=405016981&utm_source=hs_email
Pharmaceutical giants, seeing a wave of new risks and potential rewards in President Trump’s second term, are boosting their spending on lobbying firms with connections to the White House. (Payne and Lawrence, 2/23)
Politico: RFK Jr.’s Billionaire Running Mate Is Making A Comedy About The Pandemic
https://www.politico.com/news/2026/02/22/the-next-hollywood-hero-jay-bhattacharya-00791313?utm_campaign=KHN:+First+Edition&utm_medium=email&_hsenc=p2ANqtz--80_4mNt9We1GVUQWjUaYI3EcB-SUhI6F8VmdEEozVdMnB1drWwxvyvnDUMMvmqQuD0xEeho3Aluv8hifENqdr7hLDMw&_hsmi=405016981&utm_content=405016981&utm_source=hs_email
Covid contrarians tight with Robert F. Kennedy Jr. are pitching Hollywood on an unlikely leading man: National Institutes of Health Director Jay Bhattacharya. Nicole Shanahan, Kennedy’s running mate in the 2024 presidential campaign, is searching for investors to fund a movie that pokes fun at the pandemic response with a star based on Bhattacharya, who rose to prominence with his anti-lockdown manifesto and relentless tweets opposing social distancing. (Hooper, 2/22)
Politico: Trump’s Law Is Crushing The Next Generation Of RFK Jr. Disciples
https://www.politico.com/news/2026/02/23/rfk-naturopaths-student-loans-education-00790060?utm_campaign=KHN:+First+Edition&utm_medium=email&_hsenc=p2ANqtz-9D1ZxhFPxZP7GUJW9JdP5bMmXBHjUTNZNaUfZH0U5EvncI2BFHE-ZVV6pnCUsFc-PO3H1mzh29zCQfnBuDIX0cgNWBsA&_hsmi=405016981&utm_content=405016981&utm_source=hs_email
Health Secretary Robert F. Kennedy Jr. has made it his Make America Healthy Again mission to challenge the medical establishment. President Donald Trump’s signature law, the One Big Beautiful Bill Act, could entrench it. Kennedy sees America’s medical schools as bastions of groupthink that ignore the root causes of disease. But newly proposed caps on student loans that stem from the law would favor establishment institutions over nontraditional schools aligned with Kennedy’s view that Americans are sicker than ever because of what they eat, the chemicals they’re exposed to, and how little exercise they get. (Chu, 2/23)
What does today’s Supreme Court decision striking down tariffs mean for the pharmaceutical industry?
https://www.managedhealthcareexecutive.com/view/what-does-today-s-supreme-court-decision-striking-down-tariffs-mean-for-the-pharmaceutical-industry-?utm_campaign=KHN%3A%20First%20Edition&utm_medium=email&_hsenc=p2ANqtz-8i7_yrYxYjAntDkSc4u_yZkMzM0s_kCmFL5zNFTnLjUlIQZJr-luwh8KoRfMTDK_uVtQklBLyvZI5u1-8xfCkEqDm1Rw&_hsmi=405016981&utm_content=405016981&utm_source=hs_email
Managed Healthcare Executive: What Does The Supreme Court Decision Striking Down Tariffs Mean For The Pharmaceutical Industry?
The Trump administration has other legal avenues to impose tariffs on pharmaceuticals despite the Supreme Court decision striking down many of the administration’s current tariffs. In a 6-3 decision, the court ruled that President Donald Trump did not have the authority to impose tariffs under a 1977 law, the International Emergency Economic Powers Act. But at a White House press conference, Trump said there were numerous other statutes and authorities that give the president the power to impose tariffs. He cited Sections 122 and 301 of the Trade Act of 1974; Section 232 of the Trade Expansion Act of 1962; and Section 338 of the Tariff Act of 1930, commonly referred to as the Smoot-Hawley Tariff Act. He also announced that he would impose a broad tariff of 10% under Section 122 of the Trade Act of 1974, effectively replacing tariffs he imposed under the international emergency law that the court struck down. (Wehrwein, 2/21)
As More Americans Embrace Anxiety Treatment, MAHA Derides Medications By Phillip Reese February 23, 2026
https://kffhealthnews.org/news/article/anxiety-medications-ssris-prozac-zoloft-lexapro-maha-kennedy-rfk-jr/
KFF Health News: As More Americans Embrace Anxiety Treatment, MAHA Derides Medications
After a grueling year of chemotherapy, surgery, and radiation to treat breast cancer, Sadia Zapp was anxious — not the manageable hum that had long been part of her life, but something deeper, more distracting. “Every little ache, like my knee hurts,” she said, made her worry that “this is the end of the road for me.” So Zapp, a 40-year-old communications director in New York, became one of millions of Americans to start taking an anxiety medication in recent years. For her, it was the serotonin-boosting drug Lexapro. (Reese, 2/23)
New Orleans Brings Back the House Call, Sending Nurses To Visit Newborns and Moms By Rosemary Westwood, WWNO February 23, 2026
https://kffhealthnews.org/news/article/new-orleans-postpartum-home-visits-newborn-maternal-health/
KFF Health News: New Orleans Brings Back The House Call, Sending Nurses To Visit Newborns And Moms
When Lisa Bonfield gave birth to daughter Adele in late November, she was thrust into the new world of parenting, and faced an onslaught of challenges and skills to learn: breastfeeding, diapering, sleep routines, colic, crying, and all the little warning signs that something could be wrong with the baby. But unlike parents in most of the U.S., she had extra help that was once much more common: house calls. Adele was only a few weeks old when a registered nurse showed up at Bonfield’s door on Dec. 10 to check on them and offer hands-on help and advice. (Westwood, 2/23)
Health Insurer Financial Performance in 2024 Authors: Jared Ortaliza, Jeannie Fuglesten Biniek, Elizabeth Hinton, Jada Raphael, Tricia Neuman, and Cynthia Cox Published: Feb 23, 2026
https://www.kff.org/medicare/health-insurer-financial-performance/?utm_campaign=KFF-Medicare&utm_medium=email&_hsenc=p2ANqtz-_OEe4G7Vybfy8pe0-JR2Yn86TsayyUsAQokyUtCCIWzVZKtElGgVXtfSv_o9GQ5vR2CcDL12UOhS4k6Yi9aDtCB3L6Yw&_hsmi=405037724&utm_content=405037724&utm_source=hs_email
KFF Examines Insurers’ Financial Performance in 2024 Across Four Markets
An updated KFF analysis of trends in health insurers’ financial data shows that insurers’ gross margins per enrollee dipped slightly in 2024 across four markets, remaining highest in the Medicare Advantage market ($1,655), followed by the individual (non-group) market ($987), the fully insured group (employer) market ($846), and Medicaid managed care ($608).
The Medicare Advantage market’s higher margins in part reflect the fact that enrollees are older and less healthy than those in other markets, with similar percentage margins translating into higher dollar amounts.
The analysis also examines insurers’ medical-loss ratios across the four markets.
The Government’s Warning Shot? FDA and HHS Turn Up the Pressure on Compounding February 23, 2026 By Karla L. Palmer & Sara W. Koblitz —
https://www.thefdalawblog.com/2026/02/the-governments-warning-shot-fda-and-hhs-turn-up-the-pressure-on-compounding/?utm_source=rss&utm_medium=rss&utm_campaign=the-governments-warning-shot-fda-and-hhs-turn-up-the-pressure-on-compounding
Are compounders on notice? FDA may be coming for at least one of them, with a little help from its friends at the Justice Department.
On the heels of the Novo Nordisk’s Wegovy® pill launch, Hims & Hers, in a headscratcher of a promotional move, doubled down on its own compounded semaglutide pill formulation. This likely was the spark that caused FDA’s Commissioner Marty Makary to tweet a not-so-subtle threat to compounders:
FDA will take swift action against companies mass-marketing illegal copycat drugs, claiming they are similar to FDA-approved products.
domingo, 22 de febrero de 2026
Re-Centering Rights, Recovery, And Evidence In US Mental Health Policy Carlos A. Larrauri Michael Ashley Stein Vikram Patel February 17, 2026
https://www.healthaffairs.org/content/forefront/re-centering-rights-recovery-and-evidence-us-mental-health-policy
On September 10, 2025, the Substance Abuse and Mental Health Services Administration (SAMHSA) released strategic priorities that represent a significant shift in federal mental health policy. The agency’s plan emphasizes “lasting [] recovery” through “gold-standard science” and promotes the expanded use of court-ordered psychiatric hospitalization (civil commitment) and court-ordered community treatment (assisted outpatient treatment or AOT) as mechanisms for “ending crime and disorder on America’s streets.”
Without The US, The World Health Organization Cannot Fulfill Its Mission Sam F. Halabi Lawrence O. Gostin February 17, 2026
https://www.healthaffairs.org/content/forefront/without-us-world-health-organization-cannot-fulfill-its-mission
This article is the latest in the Health Affairs Forefront featured topic, “Health Policy at a Crossroads,” produced with the support of the Commonwealth Fund and the Robert Wood Johnson Foundation. Articles in this topic offer timely analysis of regulatory, legislative, and judicial developments in health policy under the Trump-Vance Administration and the 119th Congress
The Uncontrolled Policy Experiment On Trans Children And Youth Arjee Javellana Restar Kristi Gamarel Don Operario February 17, 2026
https://www.healthaffairs.org/content/forefront/uncontrolled-policy-experiment-trans-children-and-youth
On December 18, 2025, the Department of Health and Human Services and Centers for Medicare and Medicaid Services announced a new policy stating that hospitals providing gender-related hormonal or surgical interventions to trans minors will be barred from Medicare and Medicaid programs. This directive contradicts evidence-based recommendations for gender-affirming care endorsed by leading medical and health organizations, including the American Academy of Pediatrics, American Medical Association, Endocrine Society, and American Psychological Association.
HHS Proposes Sweeping Changes For 2027 Marketplace Plans (Part 3) Katie Keith February 17, 2026
https://www.healthaffairs.org/content/forefront/hhs-proposes-sweeping-changes-2027-marketplace-plans-part-3
This article is the latest in the Health Affairs Forefront featured topic, “Health Policy at a Crossroads,” produced with the support of the Commonwealth Fund. Articles in this topic offer timely analysis of regulatory, legislative, and judicial developments in health policy under the Trump-Vance Administration and the 119th Congress.
On February 9, 2026, the U.S. Department of Health and Human Services (HHS) issued a highly anticipated 577-page proposed Notice of Benefit and Payment Parameters rule for 2027 that would, if finalized, make sweeping changes to marketplace coverage under the Affordable Care Act (ACA). Comments are due on March 13. The rule was accompanied by a press release and fact sheet.
Misinformation about COVID-19 Vaccines Cost the United States $2 Billion from Hospitalizations in 2021
https://academic.oup.com/healthaffairsscholar/advance-article/doi/10.1093/haschl/qxag037/8487365?rss=1&login=false
Misinformation is a major public health threat, as it leads to unnecessary illnesses, deaths, and costs to society. In 2021, misinformation was rampant for COVID-19 vaccines, where a large portion of the US population believed in vaccine misinformation and refused vaccination.
The Equity Catastrophe: How Securitized Financing Collapses Essential Care During Health Crises
https://academic.oup.com/healthaffairsscholar/advance-article/doi/10.1093/haschl/qxag042/8493231?rss=1&login=false
Global health systems have demonstrated strong capacity for rapid outbreak containment. However, across recent health emergencies, including Ebola, COVID-19, and Mpox. These responses have repeatedly been associated with large-scale disruptions to routine essential health services and excess non-outbreak mortality, particularly among women and children. This paper examines how prevailing pandemic preparedness policies and financing arrangements can be redesigned to achieve effective outbreak containment while maintaining continuity of essential primary health care.
What Do We Really Know About Addressing Burnout Among Healthcare Workers? Maybe Less Than We Think
https://academic.oup.com/healthaffairsscholar/advance-article/doi/10.1093/haschl/qxag041/8494225?rss=1&login=false
This policy inquiry responds to the question: Are commonly held assumptions about how to address healthcare workers’ burnout truly evidence-based? We think not. Our conclusion is informed by findings from a recently completed large systematic review commissioned by the Agency for Healthcare Research and Quality (AHRQ). We highlight significant gaps in research regarding effective interventions directed at healthcare worker burnout. We include findings related to social support initiatives where limited credible evidence points to the potential for positive effects. We conclude that certainty about the effectiveness of intervention programs directed at burnout are elusive and there is a dire need for additional study using rigorous methods given the healthcare worker shortage we now face.
Aligning The MedPAC And CMS Estimates Of Coding Intensity: The Importance Of The Risk Model And Trend Michael E. Chernew Andy Johnson Paul B. Masi Karen Stockley
https://www.healthaffairs.org/content/forefront/aligning-medpac-and-cms-estimates-coding-intensity-importance-risk-model-and-trend
The growth of the Medicare Advantage (MA) program to over half of eligible Medicare beneficiaries has made MA payment a salient part of Medicare policy discussions. Those discussions often focus on aspects of the risk adjustment system—which adjusts Medicare’s payments to plans based on enrollees’ recorded health conditions and demographic information. Because FFS claims are used to both calibrate the risk adjustment model and set MA benchmarks, greater coding intensity in MA, whether accurate or not, raises Medicare spending and thus beneficiaries’ Part B premiums, which are calculated to cover about 25 percent of Part B expenses.
The Twelve-Thousand-Dollar Question: Who Picks Up The Tab For Psychedelics? Vincent Joralemon February 19, 2026
https://www.healthaffairs.org/content/forefront/twelve-thousand-dollar-question-picks-up-tab-psychedelics
In Oregon, locals can now walk into a state-licensed clinic and, for a fee, spend six hours on a supervised psilocybin (or magic mushrooms) trip for therapeutic purposes. Colorado and New Mexico are building similar programs. After decades of prohibition, psychedelic therapy is no longer a question of if—it’s a question of who can afford it.
Navigating Cell And Gene Therapy Risk In Medicaid: Lessons From The States William H. Shrank Bruce Greenstein Hannah Katch February 19, 2026
https://www.healthaffairs.org/content/forefront/navigating-cell-and-gene-therapy-risk-medicaid-lessons-states
This article is part of a Health Affairs Forefront featured topic, Medicaid Financing. Which includes analysis, proposals, and commentary that will inform policies on the state and federal levels to address sustainability, efficiency, and access to care in Medicaid programs. Submissions will be reviewed on a rolling basis until the deadline. Health Affairs Forefront alone reviews all submissions then selects, edits, and publishes them only if they meet Forefront’s editorial standards. We are grateful to Arnold Ventures for supporting this work.
Innovation Stagnation: The Plight Of Dialysis Patients In The US Suzanne Watnick February 20, 2026
https://www.healthaffairs.org/content/forefront/innovation-stagnation-plight-dialysis-patients-us
For a clinician-scientist, the modern dialysis unit should be an ideal research environment. Every year, nearly 500,000 Americans with kidney failure, better known as end-stage renal disease (ESRD), spend roughly 12 hours a week connected to machines that meticulously record multiple clinical variables. More than 80,000 additional Americans perform dialysis at home, either via peritoneal dialysis or home hemodialysis, also recording extensive data much of which are transmitted to their dialysis facility
What Excites Insiders About Health Care in 2026? Michael S. Gerber Renée M. Landers Martin Cauz Mark Speicher February 25, 2026
https://www.healthaffairs.org/do/10.1377/he20260122.74703/full/
Join Health Affairs on February 25 for an exclusive Insider virtual event featuring Insider members discussing what excites them about health care for 2026.
The US Health Spending Problem Is Still About Prices Irene Papanicolas Jonathan Cylus Luca Lorenzoni
https://www.healthaffairs.org/content/forefront/us-health-spending-problem-still-prices
For more than two decades, debates about why US health care spending is so high have been shaped by the insight articulated by Gerard Anderson, Uwe Reinhardt and Peter Hussey: that the United States does not use more health care than other high-income countries but pays much higher prices for it. The original “It’s the Prices, Stupid” argument was fundamentally about price levels, not price growth. That central insight remains as true today as when it was first articulated: across services, drugs, and inputs, the United States consistently pays substantially higher prices than its peers for comparable services, drugs, and inputs.
Practice Pattern Changes After Adoption Of Diagnostic AI Tool Used In Conjunction With Cardiac Imaging Anna Zink, Michael E. Chernew, and Hannah T. Neprash
https://www.healthaffairs.org/doi/full/10.1377/hlthaff.2025.00929
In 2018, Medicare established coverage and reimbursement for its first service using artificial intelligence (AI): computed tomography (CT) fractional flow reserve (FFRCT). FFRCT is used in conjunction with cardiac imaging to diagnose coronary artery disease. Medicare reimbursement provides the opportunity to observe clinicians’ adoption of FFRCT and examine changes in utilization, spending, clinician productivity, and patient outcomes associated with its use. In this study, we exploited variation in the timing of FFRCT adoption by clinicians, quantifying changes in practice patterns before and after adoption compared with nonadopters. We found that use of the underlying coronary artery disease test required for FFRCT increased after the adoption of FFRCT, whereas invasive test use declined. On net, per patient diagnostic spending for coronary artery disease increased. We found no evidence that adopting FFRCT facilitated earlier diagnosis of coronary artery disease, although clinicians saw a larger share of patients with coronary artery disease after adoption, and clinician productivity (that is, total visit count) increased. After clinicians adopted FFRCT, we observed a decrease in rates of cardiac-related adverse events among their patients.
sábado, 21 de febrero de 2026
American College of Chest Physicians announces CCAPP designation for advanced practice providers
https://www.news-medical.net/news/20260219/American-College-of-Chest-Physicians-announces-CCAPP-designation-for-advanced-practice-providers.aspx
The American College of Chest Physicians (CHEST) is pleased to announce the first class of advanced practice providers (APPs) to earn the CHEST Critical Care Advanced Practice Provider (CCAPP) designation.
Should drug companies be advertising to consumers?
https://www.news-medical.net/news/20260220/Should-Drug-Companies-Be-Advertising-To-Consumers.aspx
Tamar Abrams had a lousy couple of years in 2022 and '23. Both her parents died; a relationship ended; she retired from communications consulting. She moved from Arlington, Virginia, to Warren, Rhode Island, where she knew all of two people.
When it comes to health insurance, federal dollars support more than ACA plans
https://www.news-medical.net/news/20260220/When-it-comes-to-health-insurance-federal-dollars-support-more-than-ACAplans.aspx
Subsidies. Love 'em or hate them, they dominated the news during the Affordable Care Act's sign-up season, and their reduction is now hitting many enrollees in the pocketbook.
How perceived deceased emotions in after‑death communication shape and transform grief
https://www.news-medical.net/news/20260220/How-perceived-deceased-emotions-in-aftere28091death-communication-shape-and-transform-grief.aspx
An international study investigates spontaneous after-death communication to understand how participants perceive the emotional state of the deceased and how this perception influences their grieving process. The data show that these experiences are often described as transformative, with the potential to ease the sense of loss, strengthen hope, and redefine a person's relationship with death and with the one who has passed away.
Rising primary PCI rates do not correlate with lower heart attack mortality in Europe
https://www.news-medical.net/news/20260220/Rising-primary-PCI-rates-do-not-correlate-with-lower-heart-attack-mortality-in-Europe.aspx
An increase in the number of percutaneous coronary interventions does not appear to have resulted in reduced mortality rates, according to results presented today at the EAPCI Summit 2026. The summit is a new event organised by the European Association of Percutaneous Cardiovascular Interventions (EAPCI), an association of the European Society of Cardiology (ESC).
Tropical cyclones linked to rise in drug-related deaths months after landfall
https://www.news-medical.net/news/20260220/Tropical-cyclones-linked-to-rise-in-drug-related-deaths-months-after-landfall.aspx
Tropical cyclones, including hurricanes and tropical storms, are linked to increased rates of drug-related deaths up to three months after the storm passes-particularly in higher-income, White communities and among younger populations. The study of more than 30 years of data by researchers at Columbia University Mailman School of Public Health points to one overlooked health impact of climate change, which is leading to more active and severe storms.
Adults with intellectual and developmental disabilities face severe mental health disparities
https://www.news-medical.net/news/20260220/Adults-with-intellectual-and-developmental-disabilities-face-severe-mental-health-disparities.aspx
Adults with intellectual and developmental disabilities, such as autism and Down syndrome, experience substantially higher rates of anxiety and depression than the general population of adults, researchers reported today in JAMA Network Open.
Sometimes, it would be unethical not to use AI in medicine When AI outperforms clinicians, its use shouldn’t be optional
https://www.statnews.com/2026/02/20/ai-medical-ethics-doctors-unethical-not-use-ai/
By Morish Shah and Ami BhattFeb. 20, 2026
Shah is a master’s of precision health student at the University of Chicago. Bhatt is the chief innovation officer of the American College of Cardiology and inaugural chair of the FDA Digital Health Advisory Committee.
DOJ, Ohio attorney general accuse OhioHealth of driving up prices, crowding out competition Lawsuit seeks to prohibit hospital contracts that make health care more expensive
https://www.statnews.com/2026/02/20/doj-ohio-antitrust-lawsuit-ohiohealth-acontracts/
By Tara BannowFeb. 20, 2026
Hospitals and Insurance Reporter
Nature Medicine to investigate study that found cancer treatment is better in morning Sleuths point out inconsistencies in study that found big difference in timing of immunotherapy
https://www.statnews.com/2026/02/20/cancer-immunotherapy-morning-infusions-doubts-about-study/
By Angus ChenFeb. 20, 2026
Cancer Reporter
In first speech to her FDA staff, Høeg says she’ll scrutinize RSV shots and SSRIs in pregnancy Høeg also told staff to ‘question the norms’ and quoted the philosopher Ayn Rand
https://www.statnews.com/2026/02/19/tracy-beth-hoeg-fda-speech-to-staff-ssris-in-pregnancy-rsv-shots/
By Lizzy LawrenceFeb. 19, 2026
FDA Reporter
Generic Drugs Forum (GDF) 2026 April 22 - 23, 2026
https://www.fda.gov/drugs/news-events-human-drugs/generic-drugs-forum-gdf-2026-04222026?utm_medium=email&utm_source=govdelivery
Join the Small Business and Industry Assistance (SBIA) program for the annual Generic Drugs Forum two-day event designed to facilitate the development and approval of safe, effective, and high-quality generic medicines. This premier event brings together FDA subject matter experts from every aspect of the pre-ANDA and ANDA assessment programs, offering unparalleled insights and guidance.
viernes, 20 de febrero de 2026
Sometimes, it would be unethical not to use AI in medicine When AI outperforms clinicians, its use shouldn’t be optional
https://www.statnews.com/2026/02/20/ai-medical-ethics-doctors-unethical-not-use-ai/
By Morish Shah and Ami BhattFeb. 20, 2026
Shah is a master’s of precision health student at the University of Chicago. Bhatt is the chief innovation officer of the American College of Cardiology and inaugural chair of the FDA Digital Health Advisory Committee.
Biohackers and wellness influencers are pushing nicotine as part of their ‘stacks’ The stimulant that makes cigarettes so addictive is getting a reputational makeover
https://www.statnews.com/2026/02/20/nicotine-wellness-startups-productivity-boost-legal-gray-area/
By Sarah ToddFeb. 20, 2026
Reporter, Commercial Determinants of Health
Rare Disease Month Developments – Part 3: The Ugly (just kidding) – See You at Rare Disease Week February 20, 2026 By Sarah Wicks & Mark A. Tobolowsky —
https://www.thefdalawblog.com/2026/02/rare-disease-month-developments-part-3-the-ugly-just-kidding-see-you-at-rare-disease-week/?utm_source=rss&utm_medium=rss&utm_campaign=rare-disease-month-developments-part-3-the-ugly-just-kidding-see-you-at-rare-disease-week
If Part 1 of our Rare Disease Month series highlighted The Good, and Part 2 addressed The Bad, Part 3 turns to The Ugly. And by “Ugly,’ we mean something entirely different – members of Hyman, Phelps & McNamara will be well represented at Rare Disease Week (RDW) on Capitol Hill next week, convened for the 15th consecutive year by the EveryLifeFoundation for Rare Diseases.
Longer Looks: Interesting Reads You Might Have Missed
Longer Looks: Interesting Reads You Might Have Missed
Each week, KFF Health News finds longer stories for you to enjoy. Today's selections are on Black paramedics, limb lengthening, mammograms, gene-editing, and more.
https://kffhealthnews.org/morning-breakout/longer-looks-interesting-reads-you-might-have-missed-252/
Influencers Push Cognitive, Health Benefits Of Nicotine In Image Makeover
Influencers Push Cognitive, Health Benefits Of Nicotine In Image Makeover
Companies are now marketing “clean,” “modern” nicotine pouches with minimalist packaging, aimed at helping people “lock in” and achieve their goals. The catch is that most of these products have not been cleared by the FDA for sale in the U.S.
https://kffhealthnews.org/morning-breakout/influencers-push-cognitive-health-benefits-of-nicotine-in-image-makeover/
Wis. Bills To Expand Medicaid, Cancer Screenings Await Governor’s Signature
Wis. Bills To Expand Medicaid, Cancer Screenings Await Governor’s Signature
The Medicaid measure would extend coverage for new moms up to a year after giving birth. The second bill requires insurance companies to cover extra cancer screenings for women with dense breast tissue. Democratic Gov. Tony Evers is expected to sign them next week, AP reported.
https://kffhealthnews.org/morning-breakout/wis-bills-to-expand-medicaid-cancer-screenings-await-governors-signature/
NewYork-Presbyterian Hospital, Nurses Make Tentative Deal To End Walkout
NewYork-Presbyterian Hospital, Nurses Make Tentative Deal To End Walkout
The last set of holdouts picketing for better working conditions will vote on whether to ratify the agreement in the coming days. Other companies making headlines include EmblemHealth, Community Health Systems, UnitedHealthcare, Change Healthcare, Banner Health, and more.
https://kffhealthnews.org/morning-breakout/newyork-presbyterian-hospital-nurses-make-tentative-deal-to-end-walkout/
FDA’s Top Drug Regulator To Examine Safety Of SSRIs And RSV Monoclonals
FDA’s Top Drug Regulator To Examine Safety Of SSRIs And RSV Monoclonals
Tracy Beth Høeg, the fifth director of the Center for Drug Evaluation and Research since last year, says she is prioritizing the health of women and babies. Meanwhile, ACIP is postponing its meeting set for next week. Plus, measles cases continue to spread.
https://kffhealthnews.org/morning-breakout/fdas-top-drug-regulator-to-examine-safety-of-ssris-and-rsv-monoclonals/
MAHA Supporters Reel As RFK Jr. Backs Trump’s Order To Produce Glyphosate
MAHA Supporters Reel As RFK Jr. Backs Trump’s Order To Produce Glyphosate
Glyphosate is the most commonly used herbicide for a slew of U.S. crops and also the chemical in the weed killer Roundup, which is under fire in scores of lawsuits that allege it causes cancer. Ken Cook, president of the Environmental Working Group, called the move a “middle finger to every MAHA mom.”
https://kffhealthnews.org/morning-breakout/maha-supporters-reel-as-rfk-jr-backs-trumps-order-to-produce-glyphosate/
Veteran Furor Prompts VA To Halt Rule Tying Disability Ratings To Treatment
Veteran Furor Prompts VA To Halt Rule Tying Disability Ratings To Treatment
The new Department of Veterans Affairs rule would have factored in whether medication effectively treats an ailment in determining compensation for veterans with a disability. “Disabled veterans should never be forced to choose between following their doctor’s orders and protecting their earned benefits,” VFW National Commander Carol Whitmore said.
https://kffhealthnews.org/morning-breakout/veteran-furor-prompts-va-to-halt-rule-tying-disability-ratings-to-treatment/
jueves, 19 de febrero de 2026
Morning Briefing: Today's News Summaries Thursday, Feb 19 2026 8:45 AM +++ +++ ++
Morning Briefing: Today's News Summaries
Thursday, Feb 19 2026 8:45 AM
NIH Director Bhattacharya Takes On Double Duty Leading CDC — For Now
Jay Bhattacharya's acting role gives the Trump administration time to find a permanent replacement for ousted director Jim O'Neill. Plus, Moderna's mRNA flu vaccine application will be reviewed by the FDA after all.
https://kffhealthnews.org/morning-breakout/nih-director-bhattacharya-takes-on-double-duty-leading-cdc-for-now/
Trump's FDA To Require Only One Study For Drug Approvals, Not Two
In changing the longtime standard, administration officials aim to speed up the approval process. Also in the news: domestic production of glyphosate, fluoride in drinking water, and more
https://kffhealthnews.org/morning-breakout/trumps-fda-to-require-only-one-study-for-drug-approvals-not-two/
More Pregnant People Are Putting Off Prenatal Care, CDC Data Indicate
Although nearly all racial and ethnic groups experienced a downward trend, minority groups had more of a decrease in early prenatal care. The report didn't touch on reasons for the shift in care, but doctors noted access has become challenging as maternity care deserts pop up across the nation.
https://kffhealthnews.org/morning-breakout/more-pregnant-people-are-putting-off-prenatal-care-cdc-data-indicate/
New National Specialty Care Coalition Will Focus On Rural Patient Access
More than 20 health systems have joined forces to improve health care access in rural and underserved communities, Modern Healthcare reported.
https://kffhealthnews.org/morning-breakout/new-national-specialty-care-coalition-will-focus-on-rural-patient-access/
NYU Langone Ends Transgender Youth Health Program, To Dismay Of Many
Months after the Trump administration proposed a withdrawal of federal funds from hospitals providing gender transition treatments to young people, NYU Langone has announced the end of its health program. Advocates are calling for the reinstatement of the program, while hoping the city and state will help fill gaps in care.
https://kffhealthnews.org/morning-breakout/nyu-langone-ends-transgender-youth-health-program-to-dismay-of-many/
Blood Tests May Give Patients A 'Clock' For Alzheimer’s Disease, Study Finds
Although the findings are not yet accurate enough to predict a patient’s exact trajectory, The Washington Post reports that scientists created a model that could use blood test results to forecast the start of symptoms within a margin of three to four years. Other public health news is on social media, foodborne bacteria, and more.
https://kffhealthnews.org/morning-breakout/blood-tests-may-give-patients-a-clock-for-alzheimers-disease-study-finds/
Research Roundup: The Latest Science, Discoveries, And Breakthroughs
https://kffhealthnews.org/morning-breakout/research-roundup-the-latest-science-discoveries-and-breakthroughs-56/
Viewpoints: ICE Is Causing A Health Crisis; FDA’s Reversal On Moderna Vaccine Can’t Undo The Damage
https://kffhealthnews.org/morning-breakout/viewpoints-ice-is-causing-a-health-crisis-fdas-reversal-on-moderna-vaccine-cant-undo-the-damage/
The FDA’s Moderna pirouette is one more sign of chaos at the agency While the agency may get past the latest crisis, the volatility may be here to stay
https://www.statnews.com/2026/02/18/moderna-fda-reversal-vinay-prasad/
By Matthew HerperFeb. 18, 2026
Senior Writer, Medicine, Editorial Director of Events
New FDA guidance for antibiotic use in food-producing animals prompts criticism over antibiotic resistance Critics argue the effort fails to consider the impact on human health
https://www.statnews.com/pharmalot/2026/02/18/fda-livestock-guidance-antibiotic-resistance-cows-pigs-chickens/
By Ed SilvermanFeb. 18, 2026
Pharmalot Columnist, Senior Writer
Upcoming meeting of federal vaccine panel may be postponed after HHS missed deadlines ACIP meetings have become closely watched signs of Trump administration’s intent
https://www.statnews.com/2026/02/18/cdc-vaccines-acip-meeting-may-be-postponed/?utm_campaign=morning_rounds&utm_medium=email&_hsenc=p2ANqtz-8FlKaACI4b484SpzThsHDoF6wNuN7Kmike90X9MEg6KRJCTqAw169TdwFtARjtvW8_OvDual-1jiCTH4cisu2q_ZdSzQ&_hsmi=404443553&utm_content=404443553&utm_source=hs_email
By Chelsea CirruzzoFeb. 18, 2026
Washington Correspondent
Europe Targets Medicine Shortages, Supply Chain Gaps Jean-Bernard Gervais Medscape Europe February 18, 2026
Europe Targets Medicine Shortages, Supply Chain Gaps
Jean-Bernard Gervais
https://www.medscape.com/viewarticle/europe-targets-medicine-shortages-supply-chain-gaps-2026a100052k
Medscape Europe
February 18, 2026
FDA’s Latest Nudge to Phase Out Petroleum-Derived Color Additives February 19, 2026 By Riëtte van Laack —
https://www.thefdalawblog.com/2026/02/fdas-latest-nudge-to-phase-out-petroleum-derived-color-additives/?utm_source=rss&utm_medium=rss&utm_campaign=fdas-latest-nudge-to-phase-out-petroleum-derived-color-additives
As we previously reported, HHS Secretary Robert F. Kennedy, Jr. and FDA have highlighted the removal of petroleum-based synthetic dyes which remain approved for use in food as a focus of the MAHA campaign. These dyes include FD&C Green No. 3, FD&C Red No. 40, FD&C Yellow No. 5, FD&C Yellow No. 6, FD&C Blue No. 1, and FD&C Blue No. 2. Rather than rescinding the approvals for these petroleum-based synthetic dyes, a process that would involve time-consuming rulemaking and would require evidence that these color additives are unsafe, the Secretary and FDA have taken actions to “encourage” industry to voluntarily remove them from food products.
miércoles, 18 de febrero de 2026
Danaher To Acquire Medical Tech Firm Masimo For Nearly $10 Billion
Danaher To Acquire Medical Tech Firm Masimo For Nearly $10 Billion
Meanwhile, Prime Healthcare Foundation has acquired Central Maine Healthcare, and Tampa-based Moffitt Cancer Center plans an eastward expansion into Lakeland, Florida.
https://kffhealthnews.org/morning-breakout/danaher-to-acquire-medical-tech-firm-masimo-for-nearly-10-billion/
Proposed $7B Settlement Could Resolve Thousands Of Roundup Cancer Claims
Proposed $7B Settlement Could Resolve Thousands Of Roundup Cancer Claims
The settlement would still need the court's approval. However, it would guarantee a payout for cancer patients and would protect Bayer from higher costs should the Supreme Court rule against it when the case goes in front of justices in April.
https://kffhealthnews.org/morning-breakout/proposed-7b-settlement-could-resolve-thousands-of-roundup-cancer-claims/
Study Links Air Pollution To Increased Risk Of Alzheimer’s, Dementia
Study Links Air Pollution To Increased Risk Of Alzheimer’s, Dementia
Researchers examined data from more than 27.8 million Americans. There is no known cure for Alzheimer’s disease, the most common form of dementia, which affects about 57 million people worldwide. Plus: Alzheimer's affects women at an increased rate to men.
https://kffhealthnews.org/morning-breakout/study-links-air-pollution-to-increased-risk-of-alzheimers-dementia/
Illinois Wipes Out More Than $1.1B In Medical Debt From 500,000 Residents
Illinois Wipes Out More Than $1.1B In Medical Debt From 500,000 Residents
Illinois has spent about $10 million on the program so far, with each dollar spent equating to more than $100 of medical debt erased. Other news from around the nation comes out of Massachusetts, Wyoming, Florida, Connecticut, Hawaii, Michigan, and Maryland.
https://kffhealthnews.org/morning-breakout/illinois-wipes-out-more-than-1-1b-in-medical-debt-from-500000-residents/
CMS Will Cover Vaccines On Updated Schedule: ‘Go Get Your Measles Shot’
CMS Will Cover Vaccines On Updated Schedule: ‘Go Get Your Measles Shot’
Centers for Medicare & Medicaid Services Administrator Mehmet Oz is urging uptake of the MMR shot as the country's measles outbreak shows no signs of ending. He vowed that parents and patients will have access to inoculations and that the government will pick up the tab.
https://kffhealthnews.org/morning-breakout/cms-will-cover-vaccines-on-updated-schedule-go-get-your-measles-shot/
Military Rations Rife With Pesticides, Study Finds; US Floats ‘Real Food Pilot’
Military Rations Rife With Pesticides, Study Finds; US Floats ‘Real Food Pilot’
The Department of Health and Human Services has launched a program to improve meal quality at 20 military bases. Plus: Courts are receiving conflicting answers about the Trump administration's policy on pregnant detainees; the FDA no longer warns against junk autism treatments; and more.
https://kffhealthnews.org/morning-breakout/military-rations-rife-with-pesticides-study-finds-us-floats-real-food-pilot/
Editorial Biosecurity needs an expanded lens to remain effective The Lancet Planetary Health +++ +...
Global health burdens of plastics: a lifecycle assessment model from 2016 to 2040
Megan Deeney, MSca megan.deeney@lshtm.ac.uk ∙ Prof Lorie Hamelin, PhDb ∙ Claire Vialle, PhDc ∙ Prof Xiaoyu Yan, PhDd ∙ Rosemary Green, PhDa ∙ Joe Yates, MSca ∙ et al.
https://www.thelancet.com/journals/lanplh/article/PIIS2542-5196(25)00284-0/fulltext?dgcid=hubspot_update_feature_updatealerts_lanplh&utm_campaign=update-lanplh&utm_medium=email&_hsenc=p2ANqtz-_D2EvqGbwXo_6R3red7yKZ6SWfuYE8NrDGU40GGkZf4blo7XhB2Vw2C8nGuhfWCcnmMwiNWcK_6D-8VqIaSAfIirRueQ&_hsmi=404132375&utm_content=403599203&utm_source=hs_email
Zero-emissions vehicle adoption and satellite-measured NO2 air pollution in California, USA, from 2019 to 2023: a longitudinal observational study
Sandrah P Eckel, PhDa eckel@usc.edu ∙ Futu Chen, PhDa ∙ Sam J Silva, PhDa,b ∙ Daniel L Goldberg, PhDc ∙ Jill Johnston, PhDd ∙ Lawrence A Palinkas, PhDe ∙ et al.
https://www.thelancet.com/journals/lanplh/article/PIIS2542-5196(25)00257-8/fulltext?dgcid=hubspot_update_feature_updatealerts_lanplh&utm_campaign=update-lanplh&utm_medium=email&_hsenc=p2ANqtz--9_5rULVDqZcfhts2o8wfkkL77zKJcHSr-dQY9i8YirdClHi_Pns0cACz-tztRYZL5Sb6zi1htcHa1KeeGH37Ek-zecA&_hsmi=404132375&utm_content=403599203&utm_source=hs_email
Mortality and long-term exposure to source-specific PM2·5: evidence from a national cohort study in China
Prof Xia Meng, PhDa,∗ ∙ Yuchang Zhou, PhDb,∗ ∙ Su Shi, MSa,∗ ∙ Prof Shuxiao Wang, PhDc ∙ Prof Maryam Zaid, PhDd ∙ Prof Hongliang Zhang, PhDe,† ∙ et al.
https://www.thelancet.com/journals/lanplh/article/PIIS2542-5196(25)00278-5/fulltext?dgcid=hubspot_update_feature_updatealerts_lanplh&utm_campaign=update-lanplh&utm_medium=email&_hsenc=p2ANqtz-_LBU1BZwsWPY4ppUnPpC6zFVbRvAERuHNwIVOpedh4Qi8p2fzBsCXFR52M2toBPJnsonZoiBxlAirxh-UQzoPVnVl0Qw&_hsmi=404132375&utm_content=403599203&utm_source=hs_email
Editorial
Biosecurity needs an expanded lens to remain effective
The Lancet Planetary Health
https://www.thelancet.com/journals/lanplh/issue/vol10no1/PIIS2542-5196(26)X2001-0
SOCIAL MEDIA AND MENTAL HEALTH: AP: Mark Zuckerberg Set To Testify In Watershed Social Media Trial ++ ++
ALZHEIMER'S DISEASE
Newsweek: Study Of 27.8M Americans May Have Revealed Direct Alzheimer’s Cause
https://www.newsweek.com/health-alzheimers-disease-air-pollution-link-study-27m-americans-11534835?utm_campaign=KHN%3A%20First%20Edition&utm_medium=email&_hsenc=p2ANqtz-_lf_T5Dqmo4nHsPH93N5Nfhokrj0LidJoB8o_jdf9Gdul9placuO2oxPC-M0X7VZjNa5Rysq60dglSbIQotiH0qlEfWg&_hsmi=404283782&utm_content=404283782&utm_source=hs_email
Scientists have just found a direct link between air pollution and Alzheimer’s disease—suggesting that improving air quality could be an important way to prevent dementia and protect older adults. Alzheimer’s disease is the most common form of dementia, which affects about 57 million people worldwide, and there is currently no cure for it, making prevention is crucial. (Azzurra Volpe, 2/17)
MedPage Today: Alzheimer's Sex Gap: Similar Biomarkers, But Faster Decline For Women
https://www.medpagetoday.com/neurology/alzheimersdisease/119919?utm_campaign=KHN%3A%20First%20Edition&utm_medium=email&_hsenc=p2ANqtz--e_ReACwNRScZiJ7KTYQ2OXm2YrAqgOM8MnTt0o813MZtOhzayEAtSFDDZmeoW1y-A8cXK1DjFk6PL_0AtvVdjeZl6mA&_hsmi=404283782&utm_content=404283782&utm_source=hs_email
Women had worse outcomes than men at similar levels of Alzheimer's disease pathology, data from a multi-cohort analysis suggested. (George, 2/17)
SOCIAL MEDIA AND MENTAL HEALTH
AP: Mark Zuckerberg Set To Testify In Watershed Social Media Trial
https://apnews.com/article/mark-zuckerberg-trial-testimony-instagram-c8cbaa32ccbf4933ec3a7beebd6cf34b?utm_campaign=KHN%3A%20First%20Edition&utm_medium=email&_hsenc=p2ANqtz-_raI6676fZItlqNCrdwlotrsruE9KH8ffp4uxLqq017NNHkD6K48FQQFPLy3U6wn8EYhVzcGa1zu4xxRbb6IkPn_IMbg&_hsmi=404283782&utm_content=404283782&utm_source=hs_email
Mark Zuckerberg will testify in an unprecedented social media trial that questions whether Meta’s platforms deliberately addict and harm children. Meta’s CEO is expected to answer tough questions on Wednesday from attorneys representing a now 20-year-old woman identified by the initials KGM, who claims her early use of social media addicted her to the technology and exacerbated depression and suicidal thoughts. Meta Platforms and Google’s YouTube are the two remaining defendants in the case, which TikTok and Snap have settled. (Huamani and Ortutay, 2/18)
The Baltimore Sun: Excessive Social Media Use Contributes To Loneliness
https://www.baltimoresun.com/2026/02/18/how-to-reduce-loneliness/?utm_campaign=KHN%3A%20First%20Edition&utm_medium=email&_hsenc=p2ANqtz--a298rgU3KMRBIIlVpW06vA_wLdh8A2vsDqGvflSRPDMRFAcO07pqOH0oX8p5KPeRlm3CF2o9O2Nt7rNxIxAOXu4WKRg&_hsmi=404283782&utm_content=404283782&utm_source=hs_email
More than half of college students say they are lonely, but those who spend 16 to 20 hours a week on social media are most likely to feel isolated, research shows. (Hille, 2/18)
PHARMACEUTICALS: AP: Bayer Strikes $7.25 Billion Deal To Settle Roundup Cancer Lawsuits +++ +++
PHARMACEUTICALS
AP: Bayer Strikes $7.25 Billion Deal To Settle Roundup Cancer Lawsuits
https://apnews.com/article/bayer-monsanto-roundup-lawsuits-settlement-154ad7c6bdff3a91b06c4e327321160b?utm_campaign=KHN%3A%20First%20Edition&utm_medium=email&_hsenc=p2ANqtz-8IlVV8bK49QprQidrD5aAKLIiPJlhb7hfRq4M7MfdVT_PRIWBQcTn-fu2rL9DDORM6buoTlhlgLuvTDFj-Oe1cszMPLQ&_hsmi=404283782&utm_content=404283782&utm_source=hs_email
Agrochemical maker Bayer and attorneys for cancer patients announced a proposed $7.25 billion settlement Tuesday to resolve thousands of U.S. lawsuits alleging the company failed to warn people that its popular weedkiller Roundup could cause cancer. The proposed settlement comes as the U.S. Supreme Court is preparing to hear arguments in April on Bayer’s assertion that the U.S. Environmental Protection Agency’s approval of Roundup without a cancer warning should invalidate claims filed in state courts. That case would not be affected by the proposed settlement. (Lieb, 2/17)
CBS News: Nationwide Shortage Of Estrogen Patches Has Forced South Jersey Women To Find Alternatives
https://www.cbsnews.com/philadelphia/news/estrogen-shortage-hormone-replacement-therapy/?utm_campaign=KHN%3A%20First%20Edition&utm_medium=email&_hsenc=p2ANqtz--uiReq70CC2RcHAOO4pP567NcdMgbmX0IJIlwgQvMwbvJ4Wf731FRqh1t8h43-06g1qUSCe3uBmO41MkgnjNaqE50p6A&_hsmi=404283782&utm_content=404283782&utm_source=hs_email
A nationwide shortage of estrogen patches used for hormone replacement therapy has prompted many women to look for alternatives for treating symptoms of menopause. Prescriptions for HRT have increased 86%, according to one survey. But finding the popular estrogen patches is tricky now. Holly Sleppy, a 52-year-old who works at Virtua, shared her frustrations, which many menopausal women are feeling because of a shortage of the estrogen patches used to treat symptoms like hot flashes, irritability and brain fog. (Stahl, 2/17)
Bloomberg: Vitamin K Shot Safety: More Parents Skip Injection That's Not Vaccine
https://www.bloomberg.com/news/articles/2026-02-17/vitamin-k-shot-safety-more-parents-skip-injection-that-s-not-vaccine?utm_campaign=KHN%3A%20First%20Edition&utm_medium=email&_hsenc=p2ANqtz-_XgVreRtrudh6BagZOTsMEsR7-SO4fKIfcji-DC6zgAy7sOO6arMD3435VrMlACDM1NPoJLty2K9fnxn_MRTt2mHIhvg&_hsmi=404283782&utm_content=404283782&utm_source=hs_email
The 2-month-old baby arrived at the hospital with the type of bleeding in and around his brain that was so unusual Miami neurosurgeon Heather McCrea had only read about it in textbooks. The pooling blood indicated that the baby had a severe vitamin K deficiency — something usually prevented by a shot at birth. But his parents, like a growing number of Americans skeptical of injections, had declined to get the shot for their baby. (Nix, 2/17)
CIDRAP: FDA Issues New Guidance On Antibiotic Use In Food-Producing Animals
https://www.cidrap.umn.edu/antimicrobial-stewardship/fda-issues-new-guidance-antibiotic-use-food-producing-animals?utm_campaign=KHN%3A%20First%20Edition&utm_medium=email&_hsenc=p2ANqtz-9M2VV5VznBKNODmqVoGusMbbwglc6Xcavzpw7ZPPAkjRG6Do5U8zCp5mS2noMacnAuc7N5tmcXjELYHC2fRYDG8Bw5yQ&_hsmi=404283782&utm_content=404283782&utm_source=hs_email
The Food and Drug Administration (FDA) has released new guidance for veterinary drug makers to define how long medically important antibiotics should be used in livestock. (Dall, 2/17)
Stat: Compass Says Psilocybin Drug For Severe Depression Succeeds In Trials
https://www.bloomberg.com/news/articles/2026-02-17/sanofi-experimental-drug-helps-patients-with-bowel-disease?utm_campaign=KHN%3A%20First%20Edition&utm_medium=email&_hsenc=p2ANqtz-_GaEMxtOykTYIu36qW-prm26DY91YlYENR2jAAtHyiIf24BpCxOkgjBe7YthuyitelzWpHjVCs_rsBM5_lTNeAJcAkmg&_hsmi=404283782&utm_content=404283782&utm_source=hs_email
Compass Pathways on Tuesday disclosed results from two Phase 3 studies that support a potential approval of its psilocybin treatment for severe depression, but more detailed data are needed to determine how beneficial the drug would be for patients. (Chen, 2/17)
Bloomberg: Sanofi Experimental Drug Helps Patients With Bowel Disease
https://www.bloomberg.com/news/articles/2026-02-17/sanofi-experimental-drug-helps-patients-with-bowel-disease?utm_campaign=KHN%3A%20First%20Edition&utm_medium=email&_hsenc=p2ANqtz-_GaEMxtOykTYIu36qW-prm26DY91YlYENR2jAAtHyiIf24BpCxOkgjBe7YthuyitelzWpHjVCs_rsBM5_lTNeAJcAkmg&_hsmi=404283782&utm_content=404283782&utm_source=hs_email
Sanofi said an experimental medicine it’s developing with Teva Pharmaceuticals Inc. helped patients with inflammatory bowel disease. The benefits after treatment with the drug, duvakitug, were maintained over 44 weeks, Sanofi said in a statement. The 130 patients enrolled in the intermediate trial had ulcerative colitis or Crohn’s disease. Any positive news is key to Sanofi, which needs new medicines to replace its top-seller Dupixent as it ages. (Fourcade and Furlong, 2/17)
ON CAPITOL HILL: The Hill: Top Republican Eyeing FDA Overhaul ++
ON CAPITOL HILL
The Hill: Top Republican Eyeing FDA Overhaul
https://thehill.com/policy/healthcare/5741597-cassidy-report-fda-innovation/?utm_campaign=KHN%3A%20First%20Edition&utm_medium=email&_hsenc=p2ANqtz-_L6tqM4eLghj_Cc9lU5fkKA8PlQj1psIyLh3KSCeBL5rWscjTxULTpCWy0sFAvZHyxBvjzjVmOUSWiCIUW66twTqfspA&_hsmi=404283782&utm_content=404283782&utm_source=hs_email
Sen. Bill Cassidy (R-La.) on Tuesday unveiled his proposal for modernizing the Food and Drug Administration (FDA), calling on the agency to reform some of its practices and embrace innovations in order to get more products approved for patients. In the report titled “Patients and families: Building the FDA of the future,” Cassidy, chair of the Senate Committee on Health, Education, Labor, and Pensions, lamented that “unnecessary bottlenecks slow patients and consumers getting the products they need.” (Choi, 2/17)
Politico: Why Congress Failed To Reach An Obamacare Deal
https://www.politico.com/news/2026/02/17/inside-congress-failed-battle-to-keep-obamacare-premiums-from-skyrocketing-00781825?utm_campaign=KHN:+First+Edition&utm_medium=email&_hsenc=p2ANqtz-9Rxc6AFDxKOEd4mkwIrlAqT_CbklL-HxWEMwyySSSdwcVj43xDr75SR0g9eoYxFLISEFQ3CXNL9WYswwdPc2Dq-YSTUA&_hsmi=404283782&utm_content=404283782&utm_source=hs_email
Brian Fitzpatrick didn’t expect to find himself in the middle of a political brawl over health policy. The Pennsylvania Republican and former FBI agent doesn’t count the legislative area as a pillar of his portfolio. But early last fall, he joined a fledgling group of lawmakers incensed that House GOP leaders were doing nothing to extend enhanced Obamacare subsidies before they expired. The lack of action, they knew, would send health insurance premiums soaring come January 1. (King and Levien, 2/17)
THE TRUMP ADMINISTRATION: Bloomberg: CMS Head Oz Vows Continued Vaccine Coverage, Urges Measles Shots ++++++++
THE TRUMP ADMINISTRATION
Bloomberg: CMS Head Oz Vows Continued Vaccine Coverage, Urges Measles Shots
https://www.bloomberg.com/news/articles/2026-02-17/cms-head-oz-vows-continued-vaccine-coverage-urges-measles-shots?utm_campaign=KHN%3A%20First%20Edition&utm_medium=email&_hsenc=p2ANqtz-_6OMrCdN8TWCLplhzEtQsBaFijaEo6eZBJV1erAtFhC_3N3DhP8tcZBs16C2z_tjp7M4fvsuuBX7q1EfQQ6EqxLYQ3JA&_hsmi=404283782&utm_content=404283782&utm_source=hs_email
Mehmet Oz, head of the US Centers for Medicare and Medicaid Services, pledged continued insurance coverage for all recommended vaccinations in the country and urged people to get the measles shot as infections skyrocket. His comments come as the Trump administration remakes the nation’s approach to immunizations by promoting personal choice and backing away from once-universal endorsements of shots that have controlled deadly disease outbreaks. Changes to the vaccine schedule have added to mounting confusion over which vaccines will be covered by government programs that often pay for childhood shots. (Nix and Muller, 2/17)
Stat: PhRMA Forum Shows Industry Divide Between Dr. Oz, Marty Makary
https://www.statnews.com/2026/02/17/pharma-forum-highlights-industry-divide-oz-makary/?utm_campaign=KHN%3A%20First%20Edition&utm_medium=email&_hsenc=p2ANqtz--jNM1tJHERuGZWTgtBtGlI3xSOLPQtEiuO47Tv60V73XsIP-O9e5Z7HnurK2bn81sphQEVtbi0cBk7S10uMF1L3h7YdQ&_hsmi=404283782&utm_content=404283782&utm_source=hs_email
Two of health secretary Robert F. Kennedy Jr.’s top lieutenants struck decidedly different tones at a forum held Tuesday by the pharmaceutical industry group PhRMA. (Lawrence and Payne, 2/17)
Politico: Judges Decry Treatment Of Nursing And Pregnant Detainees In ICE Custody
https://www.politico.com/news/2026/02/18/pregnant-nursing-ice-detainees-00784683?nid=0000014f-1646-d88f-a1cf-5f46b7bd0000&nname=playbook&nrid=dce3ff34-c71f-442e-88e6-704b5639b9f8
A Myanmar refugee, with a nursing five-month-old at home, whisked abruptly to Texas by Immigration and Customs Enforcement. A Massachusetts woman in her third trimester, held under ICE’s guard at a hospital after experiencing medical distress in ICE detention. An Indian national who is three months pregnant and whose weight dropped to 90 pounds while in an ICE facility. Federal judges are sounding alarms about the Trump administration’s treatment of pregnant and nursing detainees in ICE custody — and the administration has given the courts conflicting, unclear answers about whether it is following its own policies that sharply restrict those detentions. (Cheney, 2/18)
ProPublica: RFK Jr.’s FDA No Longer Warns Against Ineffective, Potentially Dangerous Autism Treatments
https://www.propublica.org/article/rfk-jr-fda-removes-autism-treatments-warning?utm_campaign=KHN%3A%20First%20Edition&utm_medium=email&_hsenc=p2ANqtz-8SsDGS6S-q8xNIxQm9FFlbUPLEg5yvhiZXlBywU_JZPBL0r8K9htjRlF8Xjd5Zcf4i3VU13dPDkbNl5IvqJJKvtIXaZg&_hsmi=404283782&utm_content=404283782&utm_source=hs_email
The warning on the government website was stark. Some products and remedies claiming to treat or cure autism are being marketed deceptively and can be harmful. Among them: chelating agents, hyperbaric oxygen therapies, chlorine dioxide and raw camel milk. Now that advisory is gone. (O’Matz, 2/18)
The Hill: Trump Administration To Improve Food Quality Of Military Meals
https://thehill.com/policy/healthcare/5741493-trump-administration-improves-military-food/?utm_campaign=KHN%3A%20First%20Edition&utm_medium=email&_hsenc=p2ANqtz-_P0AcYnyI9a-SjphAgWcxSLZDVw0YZclDRe37Mb0fn8NjUVoksWBSXNfJqGD4KjFKrRPsKQ01XZdLT4nN9Q6gyLzoCaw&_hsmi=404283782&utm_content=404283782&utm_source=hs_email
The Trump administration is reportedly launching a new push to improve the quality of food at U.S. military bases after a study found that meals contained poor nutrients and harmful contaminants. The study, commissioned by Moms Across America in partnership with the Children’s Health Defense Military Chapter and Centner Academy, detected pesticides in 100 percent of sampled military meals, including Meals, Ready-to-Eat (MREs), rations and other cafeteria items. (Brams, 2/17)
The New York Times: Documenting A ‘Drastically Changing’ Scientific Landscape
https://www.nytimes.com/2026/02/17/insider/lost-science-research-cuts.html?utm_campaign=KHN%3A%20First%20Edition&utm_medium=email&_hsenc=p2ANqtz-_5I6zDHtMxZXMhTlwHfntWcS7JxQclHEjQVw0uPgAyKi9EZZBakC-KFFZ3njR8Nl-43FftYptCEbV7qldfGwkn6jLQhQ&_hsmi=404283782&utm_content=404283782&utm_source=hs_email
Since the Trump administration unfurled some of the deepest cuts to U.S. science funding in decades, thousands of jobs have been terminated or frozen at federal agencies including the Centers for Disease Control and Prevention, the National Park Service and the Environmental Protection Agency. Proposed budgets for this year include major cuts to organizations like NASA and the National Science Foundation. These cuts, some of them seemingly indiscriminate, have led to chaos and demoralization across the scientific community. (Otis, 2/17)
Modern Healthcare: How The Rural Health Transformation Program Could Boost PACE
https://www.modernhealthcare.com/post-acute-care/mh-rural-health-transformation-program-pace/?utm_campaign=KHN%3A%20First%20Edition&utm_medium=email&_hsenc=p2ANqtz-8n6uF0iVxPFUPAjSY3SOHLVNx3YemxXQZMRIL44UgqH42xxmGxDJ-b58zWSqpbDD83aRdChX0P3YQabAXAPsasJjfMag&_hsmi=404283782&utm_content=404283782&utm_source=hs_email
The $50 billion Rural Healthcare Transformation program could be a boon to a Medicare-Medicaid program designed to keep older adults out of nursing homes, if regulations and low reimbursement rates don’t get in the way. Three states — Connecticut, West Virginia and Montana — plan to tap some of the federal funds they are receiving to launch Programs of All-Inclusive Care for the Elderly. Another six states that already operate PACE — Rhode Island, Michigan, Pennsylvania, Kansas, Oklahoma and Louisiana — plan to use some of their funds to expand those efforts. (Eastabrook, 2/17)
Listen to the Latest ‘KFF Health News Minute’ February 17, 2026
https://kffhealthnews.org/news/article/listen-to-the-latest-kff-health-news-minute-2026/?utm_campaign=KHN%3A%20First%20Edition&utm_medium=email&_hsenc=p2ANqtz-9aibHeAzU6c7y6y2ABoV7FumWdbr-h3XxcsTtUh6xpGI0HGeGSK6jo1tOTqogcaRQPkTkdRmronMqfRKKQD2M8ukzPWg&_hsmi=404283782&utm_content=404283782&utm_source=hs_email
KFF Health News: Listen To The Latest 'KFF Health News Minute'
Jackie Fortiér reads the week’s news: Moves by the Trump administration have slowed cancer research, and more of America’s doctors are working into their golden years. (Cook, 2/17)
Wyoming Wants To Make Its Five-Year Federal Rural Health Funding Last ‘Forever’ By Arielle Zionts February 18, 2026
https://kffhealthnews.org/news/article/wyoming-rural-health-transformation-funding-grants/?utm_campaign=KHN%3A%20First%20Edition&utm_medium=email&_hsenc=p2ANqtz-8EVfevFVcb1hae1px7paBK3ZCH5GMEIAjw19s5qiv0cVL-btzxF0sJ3wJgel2X7WsYHk7Em0SVUDPc4rRDQhGhfARL_Q&_hsmi=404283782&utm_content=404283782&utm_source=hs_email
KFF Health News: Wyoming Wants To Make Its Five-Year Federal Rural Health Funding Last ‘Forever’
Wyoming officials say they have a plan to make five years of upcoming grants from a new $50 billion federal rural health program last “forever.” The state could tackle rural health issues long into the future by investing its awards from the Rural Health Transformation Program, the director of Wyoming’s health department, Stefan Johansson, told state lawmakers. But it’s unclear whether the maneuver will pass muster with the federal government. (Zionts, 2/18)
Red and Blue States Alike Want To Limit AI in Insurance. Trump Wants To Limit the States. By Darius Tahir and Lauren Sausser February 18, 2026
https://kffhealthnews.org/news/article/artificial-intelligence-ai-health-insurance-companies-state-regulation-trump/?utm_campaign=KHN%3A%20First%20Edition&utm_medium=email&_hsenc=p2ANqtz-_bClrhWbYS69DZr2d9i5vkKKQNMX4hD77STAfjkr-iyNtBri3TTw_OBuXHJxkZQdF-ccR0C4mo_XgiijabPkkhXiyghg&_hsmi=404283782&utm_content=404283782&utm_source=hs_email
KFF Health News: Red And Blue States Alike Want To Limit AI In Insurance. Trump Wants To Limit The States
It’s the rare policy question that unites Republican Gov. Ron DeSantis of Florida and the Democratic-led Maryland government against President Donald Trump and Gov. Gavin Newsom of California: How should health insurers use AI? Regulating artificial intelligence, especially its use by health insurers, is becoming a politically divisive topic, and it’s scrambling traditional partisan lines. (Tahir and Sausser, 2/18)
Rare Disease Month Developments, Part 2 –The Bad: Proposed Closing of an Orphan User Fee “Loophole” & Renewed Concerns Regarding FDA Consistency February 18, 2026 By James E. Valentine & Sara W. Koblitz & Mark A. Tobolowsky —
https://www.thefdalawblog.com/2026/02/rare-disease-month-developments-part-2-the-bad-proposed-closing-of-an-orphan-user-fee-loophole-renewed-concerns-regarding-fda-consistency/?utm_source=rss&utm_medium=rss&utm_campaign=rare-disease-month-developments-part-2-the-bad-proposed-closing-of-an-orphan-user-fee-loophole-renewed-concerns-regarding-fda-consistency
Rare Disease Month Developments, Part 1 – The Good: RPD PRV Program Renewed, FDA Rare Disease Hub’s 2026 Strategic Agenda & Plausible Mechanism Draft Guidance On Its Way
February 17, 2026
By Mark A. Tobolowsky & James E. Valentine & Frank J. Sasinowski —
https://www.thefdalawblog.com/2026/02/rare-disease-month-developments-part-1-the-good-rpd-prv-program-renewed-fda-rare-disease-hubs-2026-strategic-agenda-plausible-mechanism-draft-guidance-on-its-way/?utm_source=rss&utm_medium=rss&utm_campaign=rare-disease-month-developments-part-1-the-good-rpd-prv-program-renewed-fda-rare-disease-hubs-2026-strategic-agenda-plausible-mechanism-draft-guidance-on-its-way
HR Works Video Podcast: What is the Price of “Nice”? Pt. 2 By HR Daily Advisor Staff Feb 17, 2026 ++
https://hrdailyadvisor.hci.org/podcast/hr-works-video-podcast-what-is-the-price-of-nice-pt-2/?utm_medium=email&utm_source=newsletter&utm_campaign=hrda-daily
HR Works Video Podcast: What is the Price of “Nice”? Pt. 1
By HR Daily Advisor Staff Feb 10, 2026
https://hrdailyadvisor.hci.org/podcast/hr-works-video-podcast-what-is-the-price-of-nice/
martes, 17 de febrero de 2026
Compass says its psilocybin drug helped patients with severe depression in two trials Results support FDA approval, but it’s unclear how competitive the treatment will be
https://www.statnews.com/2026/02/17/compass-pathways-comp360-psilocybin-severe-depression-trial-results/
By Elaine ChenFeb. 17, 2026
Elaine Chen, a national biotech reporter, is the co-author of The Readout, a newsletter about the business, science, and politics of biotech.
When IV opioids are in short supply at the hospital, who gets pain relief? We need an ethical framework for distributing pain medication
https://www.statnews.com/2026/02/17/iv-opioid-shortages-ethics/
By Parker Crutchfield, Casey Chmura, and Abram BrummettFeb. 17, 2026
Crutchfield is a professor of medical ethics, humanities, and law at Western Michigan University Homer Stryker M.D. School of Medicine. Chmura is a second-year resident in J. Willis Hurst Internal Medicine Residency Program. Brummett is an assistant professor of medical humanities and clinical bioethics at Oakland University William Beaumont School of Medicine.
In a financial pinch, major health insurers are turning to AI for help Broadening efforts to cut costs and boost efficiency raise questions about trust and oversight
https://www.statnews.com/2026/02/17/health-insurers-expand-ai-use-undermining-providers-trust/
By Casey RossFeb. 17, 2026
Chief Investigative Reporter, Data & Technology
Colorado Deals Losses To People With Disabilities, Minors Seeking Trans Care
Colorado Deals Losses To People With Disabilities, Minors Seeking Trans Care
A governor-appointed board has preliminarily approved cutting Medicaid disability services that paid for cleaning, cooking, and laundry services. Separately, a Denver judge on Friday sided against families who sued after Children’s Hospital Colorado halted gender-affirming care for youths.
https://kffhealthnews.org/morning-breakout/colorado-deals-losses-to-people-with-disabilities-minors-seeking-trans-care/
Suscribirse a:
Comentarios (Atom)
.png)
